- Buffered Aspirin
Feline Osteoarthritis Treatment Market report gives a comprehensive outlook on across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on global market gives historical, current, and future market sizes (US$ Mn) of drug class, formulation type, distribution channel and geographic regions. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of global market. Feline osteoarthritis is an autoimmune disorder caused by infection, injury, or degenerative problems in the joints. Feline osteoarthritis mainly caused due to the genetic changes, injury, abnormal joint loading, obesity, and acromegaly. The symptoms associated with the feline osteoarthritis include pain, swollen joints, loss of muscle mass, and limited movement among others. Diagnosis of feline osteoarthritis is difficult and it cannot be diagnosed with normal symptoms. However, the disease can be identified by the Radiography (X-rays) which can reveal the joint abnormalities and bony growths in feline. Feline osteoarthritis can be treated with physical exercise, anti-inflammatories, and surgical treatment among others. In April 2017, Zoetis Inc. acquired Nexvet Biopharma Plc for strengthening its pipeline products for chronic pain management in cats and dogs
Fastest Growing Market
Increase in the prevalence of obesity in felines, lack of nutritional feed, increase in the R&D activities for the innovation of newer drugs for feline arthritis, and rise in feline adoption rate are anticipated to fuel the feline osteoarthritis management market. Moreover, ongoing clinical trials for feline osteoarthritis treatment, rise in animal welfare expenditure, and increase in the number of elder cats (cats with more than 7 years are more prone to osteoarthritis disease) are expected to propel the feline osteoarthritis treatment market over the forecast period. However, stringent regulatory policies for the approval of veterinary medicines, complexity in early-stage disease diagnosis, less number of treatment options in the market, and lack of awareness about the disease in rural areas are the factors restraining the growth of feline osteoarthritis management market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.